USD10
ABBV Shares
About AbbVieAbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
USD10
ABBV Shares
About AbbVieAbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Stats
TRADING WINDOW
Closed
OPENS AT
Apr 9 at 1:30 PM GMT+0
MARKET CAP
$371.70B
OPEN PRICE
Not enough data
LOW (1Y)
$164.39
HIGH (1Y)
$244.81
LOW (24H)
$204.56
HIGH (24H)
$212.21
VOLUME (24H)
$661.00
99.99%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $207.80 | |
1 Week | $214.37 | |
1 Month | $227.95 | |
1 Year | $174.20 |
Past performance is not a reliable indicator of future results.
Discover more
Popular stocks
Explore other stocks
Popular cryptocurrencies
Most popular conversions
Popular derivatives
Learn how to buy popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
